-
-
-
-
-
-
-
BioLineRx (BLRX) Reports Publication of GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide and G-CSF
-
-
-
-
-
-
-
BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors
-
-
-
-
-
-
-
Pre-Open Movers 08/04: (YELP) (GPRO) (ANET) Higher; (EFII) (AAOI) (PI) Lower (more...)
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

